Time to vasopressor initiation from the first hypotensive episode was not significantly associated with 90-day mortality or vasopressor-free days in patients with septic shock, according to a new ...

With this in mind, the recent VANISH trial [4] sought to determine whether AVP in higher than previously used doses (up to 0.06 U/min) would improve renal outcomes compared with norepinephrine.

SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...

Vasopressors are a group of medicines that constrict (tighten) blood vessels and raise blood pressure. They’re used to treat severely low blood pressure, especially in people who are critically ill, ...

Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this ...

Despite advancements in sepsis management, mortality rates remain high. In 2011, 1 in 18 deaths in Canada involved sepsis.1 Delays in achieving adequate mean arterial pressure (MAP) are associated ...

Postoperative AKI is more likely among surgery patients who experience intraoperative hypotension as well as those receiving the vasopressor norepinephrine. Both intraoperative hypotension and ...

For patients with in-hospital cardiac arrest (IHCA), adding a vasopressor and steroid shortly after epinephrine improves return of spontaneous circulation (ROSC), according to the randomized VAM-IHCA ...